Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Salivary Asprosin, IL-39,IL-40 and IL-1β Levels in Diabetic Patients with Periodontitis

NCT06735313 is registered in ClinicalTrials.gov with Necmettin Erbakan University as lead sponsor.

NCT NCT06735313
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06735313 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Salivary Asprosin, IL-39,IL-40 and IL-1β Levels in Diabetic Patients with Periodontitis
Lead sponsor
Necmettin Erbakan University
Phase
Not applicable
Overall status
Not yet recruiting
Start date
January 10, 2025
Completion date
February 20, 2025
Enrollment
176 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

asprosin, diabetes mellitus, interleukin 1-beta, periodontal disease